|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-1-31
|
|
pubmed:abstractText |
Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
669-72
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16447112-Adolescent,
pubmed-meshheading:16447112-Adult,
pubmed-meshheading:16447112-Antiviral Agents,
pubmed-meshheading:16447112-Hepatitis C,
pubmed-meshheading:16447112-Humans,
pubmed-meshheading:16447112-Patient Selection,
pubmed-meshheading:16447112-RNA, Viral,
pubmed-meshheading:16447112-Risk Factors,
pubmed-meshheading:16447112-Substance Abuse, Intravenous,
pubmed-meshheading:16447112-United States
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
|
|
pubmed:affiliation |
National Development and Research Institutes, Center for Drug Use and HIV Research, New York, NY, 10010, USA. hagan@ndri.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
